
Shield Biotech Pvt Ltd
Founded in 2001 and headquartered in Delhi, India.
Founded in 2001 and headquartered in Delhi, India.
Delhi, India
+91-XXXXXXXXXX
U74899DL2001PTC111467
111467
Private Limited Indian Non-Government Company
28 Jun 2001
29 Sep 2009
31 Mar 2009
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Satish Yadav ![]() | Director | 28-Jun-2001 | Current |
Meenu Goel ![]() | Director | 28-Jun-2001 | Current |
Rajiv Mittal ![]() | Director | 18-Dec-2003 | Current |
Enhance accessibility to Shield Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Shield Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Meenu Goel and Rajiv Mittal are mutual person
Meenu Goel is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Shield Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Shield Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shield Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Shield Biotech Pvt Ltd last Annual general meeting of members was held on 29 Sep 2009 as per latest MCA records.
Shield Biotech Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2009 with Roc Delhi.
Rajiv Mittal was appointed as a Director was appointed as a Director on 18 Dec 2003 & has been associated with this company since 21 years 2 months .
Meenu Goel was appointed as a Director was appointed as a Director on 28 Jun 2001 & has been associated with this company since 23 years 8 months .
Satish Yadav was appointed as a Director was appointed as a Director on 28 Jun 2001 & has been associated with this company since 23 years 8 months .
Shield Biotech Pvt Ltd was registered on 28 Jun 2001 with Roc Delhi & aged 23 years 8 months as per MCA records.
Shield Biotech Pvt Ltd was incorporated on 28 Jun 2001.
The authorized share capital of Shield Biotech Pvt Ltd is ₹ 0.20 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Shield Biotech Pvt Ltd.
As per Ministry of Corporate Affairs (Mca), the registered address of Shield Biotech Pvt Ltd is A-31 Badli Extn India, Delhi, 110042.
The corporate identification number (CIN) of Shield Biotech Pvt Ltd is U74899DL2001PTC111467 and the company number is 111467 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Shield Biotech Pvt Ltd was filed with the ROC on 31 Mar 2009.
Search company & director profiles for free and gain access to critical business data.